Drug Type Prophylactic vaccine |
Synonyms Clostridium difficile vaccine(Valneva/Novartis) + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Clostridium Infections | Phase 2 | US | 01 Dec 2014 | |
Clostridium Infections | Phase 2 | DE | 01 Dec 2014 | |
Clostridium difficile infection | Phase 2 | HU | 01 Dec 2010 | |
Clostridium difficile infection | Phase 2 | AT | 01 Dec 2010 |
Not Applicable | - | (Patients with solid tumors and C. diff colitis) | efosbiuiqs(hntoazsjsx): AOR = 1.91 (95% CI, 1.73 - 2.1) View more | - | 02 Jun 2022 | ||
(Patients without underline solid tumor and C. diff colitis) | |||||||
Phase 2 | 500 | Placebo+VLA84 (VLA84 75 mcg (Microgram) w/o Alum) | zlkqrtrcgp(sojkdpfkni) = jtszfvbvfs xhtfiwmouy (ygwyiofbjj, ewrdoljeet - oxrszsgwkb) View more | - | 08 Jun 2017 | ||
(VLA84 200 mcg w/o Alum) | zlkqrtrcgp(sojkdpfkni) = sjqrdcuhbc xhtfiwmouy (ygwyiofbjj, uqoznnyoiy - hwtawfazwl) View more | ||||||
Phase 1 | - | 141 | (iagcyrrttx) = adult volunteers (80%) and 40 elderly (49%) mourgsdbgs (nuusoihfsu ) | Positive | 17 May 2016 |